Sequoia raises $2.85 bn to fund startups in India, Southeast Asia
The U.S.-based investor has allocated $2 billion for the Indian venture and growth funds.
The U.S.-based investor has allocated $2 billion for the Indian venture and growth funds.
The Sequoia-backed company plans to utilise the funds to accelerate its drug discovery programmes and ramp up the clinical genomic testing market by expanding in tier-II and tier-III cities in India.
The venture capital firm in a memo alerts its portfolio companies to prepare itself for tough economic scenarios that may play out.
The fintech startup wants to fill the trade finance gap in India and globally by using technology to assess credit risk.
Angel investor Sanjay Mehta explains why early-stage deals are declining in India, the mistakes angel investors make, and the emerging breed of seed investors